RecruitingNCT04962815

Ceribell Delirium Data Collection Study


Sponsor

Ceribell Inc.

Enrollment

200 participants

Start Date

Nov 10, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Electroencephalogram (EEG) Test for people with delirium. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEElectroencephalogram (EEG) Test

EEG test and delirium assessments will be performed on subjects experiencing delirium in the ICU.


Locations(7)

Stanford University

Stanford, California, United States

Naples Community Hospital

Naples, Florida, United States

University of Iowa Hospitals & Clinics

Iowa City, Iowa, United States

Mercy

St Louis, Missouri, United States

Cooper Health

Camden, New Jersey, United States

UNC Health Rex

Raleigh, North Carolina, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04962815


Related Trials